Lakewood-Amedex Biotherapeutics (LABT) Proxy filing summary

Executive summary

• Annual shareholder meeting scheduled for September 22, 2026, at 10:00 a.m. Eastern Time via virtual platform.

• Shareholders can access proxy materials online and must vote by September 21, 2026, at 11:59 PM.

• Meeting access and voting instructions provided, with technical support available during the event.

Voting matters and shareholder proposals

• Election of four directors: Kelvin Cooper, Leonard J. DeRoma, Doug Manion, and Joseph Tucker.

• Proposal to amend articles of incorporation to increase authorized common stock from 12,500,000 to 100,000,000.

• Proposal to authorize the board to effect one or more reverse stock splits up to a 1:20 ratio.

• Proposal to amend the 2020 Equity Incentive Plan to increase shares available for issuance to 400,000.

• Ratification of appointment of independent registered public accounting firm.

Board of directors and corporate governance

• Board recommends voting "FOR" all proposals presented at the meeting.